Vir Biotechnology Inc (VIR)
8.03
+0.07
(+0.88%)
USD |
NASDAQ |
Apr 19, 10:47
Vir Biotechnology Price to Book Value: 0.6818 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 0.6759 |
| April 17, 2024 | 0.7005 |
| April 16, 2024 | 0.7099 |
| April 15, 2024 | 0.7277 |
| April 12, 2024 | 0.7617 |
| April 11, 2024 | 0.7846 |
| April 10, 2024 | 0.7719 |
| April 09, 2024 | 0.8092 |
| April 08, 2024 | 0.8058 |
| April 05, 2024 | 0.7931 |
| April 04, 2024 | 0.8041 |
| April 03, 2024 | 0.8228 |
| April 02, 2024 | 0.8169 |
| April 01, 2024 | 0.8661 |
| March 28, 2024 | 0.8602 |
| March 27, 2024 | 0.8576 |
| March 26, 2024 | 0.8466 |
| March 25, 2024 | 0.8491 |
| March 22, 2024 | 0.8534 |
| March 21, 2024 | 0.8568 |
| March 20, 2024 | 0.8636 |
| March 19, 2024 | 0.8491 |
| March 18, 2024 | 0.9069 |
| March 15, 2024 | 0.9137 |
| March 14, 2024 | 0.8933 |
| Date | Value |
|---|---|
| March 13, 2024 | 0.9298 |
| March 12, 2024 | 0.9111 |
| March 11, 2024 | 0.968 |
| March 08, 2024 | 0.9646 |
| March 07, 2024 | 0.9561 |
| March 06, 2024 | 0.9273 |
| March 05, 2024 | 0.9239 |
| March 04, 2024 | 0.9502 |
| March 01, 2024 | 0.9544 |
| February 29, 2024 | 0.9544 |
| February 28, 2024 | 0.985 |
| February 27, 2024 | 0.9706 |
| February 26, 2024 | 1.010 |
| February 23, 2024 | 0.9791 |
| February 22, 2024 | 0.8746 |
| February 21, 2024 | 0.8585 |
| February 20, 2024 | 0.8687 |
| February 16, 2024 | 0.8704 |
| February 15, 2024 | 0.8738 |
| February 14, 2024 | 0.8298 |
| February 13, 2024 | 0.7501 |
| February 12, 2024 | 0.8255 |
| February 09, 2024 | 0.7874 |
| February 08, 2024 | 0.7823 |
| February 07, 2024 | 0.7679 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6232
Minimum
Oct 27 2023
15.29
Maximum
Feb 27 2020
4.503
Average
2.608
Median
Feb 24 2022
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.809 |
| Vistagen Therapeutics Inc | 1.035 |
| Immuneering Corp | 0.5625 |
| SeaStar Medical Holding Corp | -- |
| NovaBay Pharmaceuticals Inc | 1.754 |
Price to Book Value Related Metrics
| PS Ratio | 27.27 |
| Price | 8.03 |
| Earnings Yield | -57.16% |
| Market Cap | 1.084B |